Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1663510

registered interest
date	13/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of prioritising the covid-19 vaccine booster programme for people diagnosed with long-covid.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	201364
answer	answer is ministerial correction date of answer 20/10/2023 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) is an independent group of experts who advise the Government health departments in the four nations of the United Kingdom on immunisations and the prevention of infectious disease. On 8 August 2023, the Government accepted advice from the JCVI on who should be offered COVID-19 vaccination in autumn 2023.</p><p>The primary aim of the COVID-19 vaccination programme remains the prevention of severe illness, namely hospitalisations and deaths, arising from COVID-19. The JCVI advice is to focus the offer of vaccination on those at greatest risk of serious disease or at high risk of transmitting the disease to vulnerable individuals. For this autumn the eligible groups for vaccination are residents and staff in a care home for older adults, all adults aged 65 years old and over, persons aged 6 months to 64 years old in a clinical risk group, frontline health and social care workers, persons aged 12 to 64 years old who are household contacts and persons aged 16 to 64 years old who are carers.</p><p>The clinical risk groups for COVID-19 vaccination are defined in the UK Health Security Agency’s ‘Green Book’ on vaccines and immunisation Chapter 14a tables 3 and 4. Post-COVID Syndrome (long COVID) is not currently identified by the JCVI as one of these conditions. The JCVI considered post-COVID syndromes when developing advice for autumn 2023 and concluded that there is not currently sufficient evidence to support making individuals experiencing post-COVID syndrome an eligible group for vaccination.</p><p>To support individuals with long COVID, NHS England has set out a long COVID action plan, including establishing a nationwide network of specialist clinics. Anyone who is concerned about ongoing symptoms following COVID-19 can find information and advice on the ‘NHS Your COVID Recovery’ website. The JCVI will continue to review evidence and will provide further advice regarding future vaccination programmes in due course.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 20/10/2023 11:04:10 answering member 4492 label Biography information for Maria Caulfield
tabling member	4518 label Biography information for Tulip Siddiq

1661082

registered interest
date	15/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bupropion and Lisdexamfetamine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the supply of (a) Lisdexamfetamine and (b) Bupropion Hydrochloride.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	199794
answer	answer is ministerial correction date of answer 21/09/2023 answer text <p>The Department is aware of intermittent supply disruptions affecting Elvanse (lisdexamfetamine) capsules. We continue to work with the respective manufacturer to ensure continuous supply is resumed quickly. However, we can confirm that Elvanse 20mg, 40mg and 60mg capsules are currently in stock and pharmacies should be able to obtain stock via normal wholesaler routes.</p><p>We are also aware of a shortage with Bupropion. The resupply date of this product is still to be confirmed. We have issued comprehensive management guidance to healthcare professionals on this shortage in December 2022. Guidance advises on the management of patients who require this medication for both licensed and off-label indications. Clinicians can advise patients on suitable alternative products, and other management options that can be considered. This includes unlicensed bupropion 150mg modified release tablets which have been sourced.</p> answering member constituency Colchester answering member printed Will Quince question first answered 21/09/2023 09:29:36 answering member 4423 label Biography information for Will Quince
tabling member	4518 label Biography information for Tulip Siddiq

1659321

registered interest
date	08/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Strokes: Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to increase access to thrombectomy treatment for stroke patients.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	198508
answer	answer is ministerial correction date of answer 14/09/2023 answer text <p>Thrombectomy is available in 24 centres in England. The National Health Service is committed to bringing about a tenfold increase in the delivery of mechanical thrombectomy from 1% to 10%. Progress has been made, with latest data showing that 3.3% of patients are receiving a thrombectomy following a stroke.</p><p><br> NHS England are taking steps to increase access to thrombectomy treatment for stroke patients by expanding access, with six centres currently offering 24/7 services, eight services currently providing extended hours and the remainder offering in-hours or a limited service. All thrombectomy providers and integrated stroke delivery networks are actively working to provide access to 24/7 services across England.</p><p>In addition, NHS England have worked with the General Medical Council in approving the thrombectomy curriculum and credentials to support non-interventional neuroradiologists to conduct thrombectomy and increase the number of thrombectomies that can be delivered.</p> answering member constituency Colchester answering member printed Will Quince question first answered 14/09/2023 09:56:46 answering member 4423 label Biography information for Will Quince
tabling member	4518 label Biography information for Tulip Siddiq

1657458

registered interest
date	01/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Ciliary Dyskinesia: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure children with primary ciliary dyskinesia receive similar care to those with cystic fibrosis.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	197023
answer	answer is ministerial correction date of answer 11/09/2023 answer text <p>The Government is committed to improving the lives of those living with rare diseases such as primary ciliary dyskinesia.</p><p>In 2021, the Government published the UK Rare Diseases Framework, providing a national vision for how to improve the lives of those living with rare diseases. The framework lists four priorities collaboratively developed with the rare disease community: helping patients get a final diagnosis faster; increasing awareness of rare diseases among healthcare professionals; better coordination of care; and improving access to specialist care, treatments and drugs.</p><p>The framework committed to nation-specific action plans and England published its second Rare Diseases Action Plan in February this year. The framework and action plans are not disease specific, but aim to improve the lives of all people living with rare diseases.</p> answering member constituency Colchester answering member printed Will Quince question first answered 11/09/2023 16:56:26 answering member 4423 label Biography information for Will Quince
tabling member	4518 label Biography information for Tulip Siddiq

1652976

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to stop hospitals sending results letters with advertisements for private healthcare included.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	194067
answer	answer is ministerial correction date of answer 19/07/2023 answer text <p>The Department has issued guidance to National Health Service trusts on the promotion of private healthcare to NHS patients, including sending results letters with advertisements for private healthcare included. NHS Identity guidance states that “when NHS Trusts offer private healthcare services, they should market and promote their private healthcare services completely separately. They should not market or promote these services within their NHS communications to patients and the public.”</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/07/2023 09:47:18 answering member 4423 label Biography information for Will Quince
tabling member	4518 label Biography information for Tulip Siddiq

1644671

registered interest
date	14/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to improve diabetes care in the Major Conditions Strategy.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	189639
answer	answer is ministerial correction date of answer 23/06/2023 answer text <p>Action on diabetes will be included in the Major Conditions Strategy as it is an important risk factor for cardiovascular disease. The strategy will aim to improve care and health outcomes for those living with multiple conditions and an increasingly complex set of needs.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 23/06/2023 12:44:50 answering member 4527 label Biography information for Helen Whately
tabling member	4518 label Biography information for Tulip Siddiq

1644672

registered interest
date	14/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	General Practitioners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people are able to access face to face appointments with GPs.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	189640
answer	answer is ministerial correction date of answer 19/06/2023 answer text <p>We are investing at least £1.5 billion to create an additional 50 million general practice appointments by 2024 by growing and diversifying the workforce. We have recruited over 29,000 additional primary care staff, and there are nearly 2,000 more doctors in general practice compared to 2019. In the twelve months to April 2023, there were 346.8 million appointments booked across England, up by 38.9 million compared to the twelve months up to April 2019.</p><p>The National Health Service is clear that general practices must provide face to face appointments, alongside remote consultations, and patients’ input into consultation type should be sought and their preferences for face-to-face care respected unless there are good clinical reasons to the contrary. The proportion of face-to-face appointments were 70.0% in April 2023, compared to April 2022 (62.9%) it is up by 7.1 percentage points.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 19/06/2023 16:02:37 answering member 4679 label Biography information for Neil O'Brien
tabling member	4518 label Biography information for Tulip Siddiq

1644676

registered interest
date	14/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes: Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce the number of underage young people vaping.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	189643
answer	answer is ministerial correction date of answer 19/06/2023 answer text <p>We have regulations in place to discourage underage vaping. The law protects children through restricting sales of vapes to over 18 year olds only, limiting nicotine content, refill bottle and tank sizes, labelling requirements and through advertising restrictions.</p><p>However, given the changing circumstances surrounding vapes, the Office for Health Improvement and Disparities (OHID) has launched a call for evidence to identify opportunities to reduce the number of children accessing and using vape products.</p><p>The call for evidence has now closed. The Government is currently considering a range of options based on the evidence provided, including potential changes to vaping policy and regulations.</p><p>In October 2022, we published new content on the potential risks of vaping for young people on the FRANK and Better Health websites and we have provided input to educational resources produced by partners including the PSHE Association. We will shortly be adding new resources for schools on OHID’s Schools Zone web platform.</p><p>We are also developing a new resource pack for schools on vaping which will be made available by July.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 19/06/2023 16:08:18 answering member 4679 label Biography information for Neil O'Brien
tabling member	4518 label Biography information for Tulip Siddiq

1626150

registered interest
date	09/05/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve early diagnosis rates for (a) children, (b) teenagers and (c) young adults with sarcoma cancers.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	184141
answer	answer is ministerial correction date of answer 15/05/2023 answer text <p>Improving early diagnosis of cancer is a priority for the National Health Service. That is why one of the core ambitions in the NHS Long Term Plan is to diagnose 75% of cancers at stage 1 or 2 by 2028, up from 52%, seen between January 2020 to December 2020.</p><p>NHS England’s comprehensive Early Diagnosis strategy is based on six core strands of activity, from raising awareness of cancer symptoms and encouraging people to come forward, to implementing targeted interventions for particular cancer types that we know have previously experienced later stages of diagnosis.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 15/05/2023 15:48:20 answering member 4527 label Biography information for Helen Whately
tabling member	4518 label Biography information for Tulip Siddiq

1626151

registered interest
date	09/05/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Phenytoin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Competition and Markets Authority finding in 2022 that Pfizer and Flynn charged the NHS unfairly high prices for phenytoin sodium capsules for over four years, what steps his Department is taking to help prevent the NHS from being overcharged for drugs.
tabling member constituency	Hampstead and Kilburn
tabling member printed	Tulip Siddiq
uin	184142
answer	answer is ministerial correction date of answer 16/05/2023 answer text <p>The United Kingdom has well established systems for controlling costs and ensuring we get value for money for spending on medicines. For unbranded generic medicines the Department relies on competition to keep prices down. This has led to some of the lowest prices in Europe and allows prices to react to the market. In an international market this ensures that when demand is high and supply is low, prices in the UK can increase to help secure the availability of medicines for UK patients.</p><p>Where competition does not appear to be working, the Department alerts the Competition and Markets Authority (CMA). Where the CMA finds that a company has breached competition law by charging excessive prices it can impose a fine as well as order companies to reduce their prices. In those instances, the Department will seek damages and invest that money back into the National Health Service. Investigations and infringements decisions by the CMA are publicly available on the CMA’s website.</p> answering member constituency Colchester answering member printed Will Quince question first answered 16/05/2023 10:41:11 answering member 4423 label Biography information for Will Quince
tabling member	4518 label Biography information for Tulip Siddiq